BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1583623)

  • 1. Biochemical characterization of a subtype pancreatic cholecystokinin receptor and of its agonist binding domain.
    Poirot SS; Dufresne M; Jiménez J; Vaysse N; Fourmy D
    J Recept Res; 1992; 12(2):233-53. PubMed ID: 1583623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure.
    Fourmy D; Lopez P; Poirot S; Jimenez J; Dufresne M; Moroder L; Powers SP; Vaysse N
    Eur J Biochem; 1989 Nov; 185(2):397-403. PubMed ID: 2583188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune recognition of affinity-labelled cholecystokinin receptor.
    Dufresne M; Poirot S; Jimenez J; Cuber JC; Vaysse N; Fourmy D
    Eur J Biochem; 1990 Jul; 191(1):141-6. PubMed ID: 2379496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of A-subtype pancreatic cholecystokinin receptor by immunoaffinity chromatography.
    Dufresne M; Poirot S; Jimenez J; Vaysse N; Fourmy D
    Biochimie; 1992 Feb; 74(2):149-51. PubMed ID: 1581390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electric properties of photoaffinity-labelled pancreatic A-subtype cholecystokinin.
    Jiménez J; Dufresne M; Poirot S; Vaysse N; Fourmy D
    J Chromatogr; 1990 Jul; 511():333-9. PubMed ID: 2211916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor.
    Pearson RK; Miller LJ; Hadac EM; Powers SP
    J Biol Chem; 1987 Oct; 262(28):13850-6. PubMed ID: 3654639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of photoaffinity probes containing poly(ethylene glycol) spacers for topographical mapping of the cholecystokinin receptor complex.
    Powers SP; Foo I; Pinon D; Klueppelberg UG; Hedstrom JF; Miller LJ
    Biochemistry; 1991 Jan; 30(3):676-82. PubMed ID: 1899032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
    Klueppelberg UG; Molero X; Barrett RW; Miller LJ
    Mol Pharmacol; 1990 Aug; 38(2):159-63. PubMed ID: 2200953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease peptide mapping of affinity-labeled rat pancreatic cholecystokinin-binding proteins.
    Klueppelberg UG; Powers SP; Miller LJ
    Biochemistry; 1989 Aug; 28(17):7124-9. PubMed ID: 2819053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cholecystokinin receptors in toad retina.
    Bone EA; Rosenzweig SA
    Peptides; 1988; 9(2):373-81. PubMed ID: 3131747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
    Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas.
    Le Meuth V; Philouze-Rome V; Le Huerou-Luron I; Formal M; Vaysse N; Gespach C; Guilloteau P; Fourmy D
    Endocrinology; 1993 Sep; 133(3):1182-91. PubMed ID: 8365360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of the pancreatic cholecystokinin receptor.
    Szecowka J; Hallden G; Goldfine ID; Williams JA
    Regul Pept; 1989 Mar; 24(3):215-24. PubMed ID: 2710962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of a phenethyl ester analogue of cholecystokinin to the solubilized pancreatic cholecystokinin receptor: use in ligand-affinity chromatography.
    Miller LJ; Hadac EM; Gates LK; Gaisano HY
    Biochem Biophys Res Commun; 1992 Mar; 183(2):396-404. PubMed ID: 1550549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of the rat pancreatic cholecystokinin receptor.
    Duong LT; Hadac EM; Miller LJ; Vlasuk GP
    J Biol Chem; 1989 Oct; 264(30):17990-6. PubMed ID: 2808360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated.
    Pearson RK; Hadac EM; Miller LJ
    Gastroenterology; 1986 Jun; 90(6):1985-91. PubMed ID: 3009263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a nitrotryptophan-containing peptide for photoaffinity labeling the pancreatic cholecystokinin receptor.
    Klueppelberg UG; Gaisano HY; Powers SP; Miller LJ
    Biochemistry; 1989 Apr; 28(8):3463-8. PubMed ID: 2742849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemical characterization of the native pancreatic cholecystokinin receptor using affinity labeling approaches.
    Miller LJ
    Yale J Biol Med; 1992; 65(5):441-8; discussion 465-9. PubMed ID: 1340061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity labeling the bovine gallbladder cholecystokinin receptor using a battery of probes.
    Schjoldager B; Powers SP; Miller LJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G579-86. PubMed ID: 3056035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.